Grey matter and cognitive patterns in cognitive impaired subjects using CSF biomarker cut-offs
| dc.contributor.author | Miralbell Blanch, Júlia | |
| dc.contributor.author | Spulber, Gabriela | |
| dc.contributor.author | Hooshmand, Babak | |
| dc.contributor.author | Besga, Ariadna | |
| dc.contributor.author | Mataró Serrat, Maria | |
| dc.contributor.author | Cedazo-Mínguez, Ángel | |
| dc.contributor.author | Kivipelto, Miia | |
| dc.contributor.author | Wahlund, Lars-Olof | |
| dc.date.accessioned | 2026-01-26T17:32:38Z | |
| dc.date.available | 2026-01-26T17:32:38Z | |
| dc.date.issued | 2012 | |
| dc.date.updated | 2026-01-26T17:32:38Z | |
| dc.description.abstract | The aim of this study was to investigate brain tissue volumes, grey matter (GM) distribution, and cognitive performance for cognitively impaired subjects using cerebrospinal fluid (CSF) biomarker cut-offs as grouping criteria. 41 subjects attending the Memory Clinic, Karolinska University Hospital, Huddinge, Sweden, were divided into groups based on normal or abnormal CSF levels of Aβ1-42, t-tau, and p-tau181. SIENAX algorithms were employed for brain tissue volumes estimation and voxel-based morphometry (VBM) for mapping the differences in GM patterns. VBM revealed significant lower GM volumes in temporo-parietal, occipital, and prefrontal cortices for those subjects belonging to abnormal CSF t-tau and p-tau181 groups. No differences were found between groups according to CSF Aβ1-42 cut-offs. Patients with abnormal CSF p-tau181 showed lower cognitive performance compared to those with normal levels. Patients with abnormal levels of CSF tau (but not Aβ1-42) showed an Alzheimer's disease-like pattern for both GM distribution and cognitive profile, compared to those with normal levels. These results support the hypothesis that CSF t-tau or p-tau181 levels may be of direct value for the evaluation of disease severity. | |
| dc.format.extent | 9 p. | |
| dc.format.mimetype | application/pdf | |
| dc.identifier.idgrec | 605108 | |
| dc.identifier.issn | 1387-2877 | |
| dc.identifier.uri | https://hdl.handle.net/2445/226185 | |
| dc.language.iso | eng | |
| dc.publisher | IOS Press | |
| dc.relation.isformatof | Reproducció del document publicat a: https://doi.org/10.3233/JAD-2012-111553 | |
| dc.relation.ispartof | Journal of Alzheimer's Disease, 2012, vol. 29, num.4, p. 741-749 | |
| dc.relation.uri | https://doi.org/10.3233/JAD-2012-111553 | |
| dc.rights | (c) Miralbell, J. et al., 2012 | |
| dc.rights.accessRights | info:eu-repo/semantics/openAccess | |
| dc.subject.classification | Marcadors bioquímics | |
| dc.subject.classification | Trastorns de la cognició | |
| dc.subject.classification | Cervell | |
| dc.subject.other | Biochemical markers | |
| dc.subject.other | Cognition disorders | |
| dc.subject.other | Brain | |
| dc.title | Grey matter and cognitive patterns in cognitive impaired subjects using CSF biomarker cut-offs | |
| dc.type | info:eu-repo/semantics/article | |
| dc.type | info:eu-repo/semantics/publishedVersion |
Fitxers
Paquet original
1 - 1 de 1